Boundless Bio ratios data for the quarter ended Jun 2026. These financial ratios cover 14 quarters of results from Mar 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Efficiency | ||||||||||||||
| Assets Average (Quarter)Assets Avg. (Qtr) | 123.49M | 152.64M | 181.65M | 190.75M | 198.83M | 185.35M | 174.09M | 162.89M | 149.01M | 107.36M | ||||
| Leverage & Solvency | ||||||||||||||
| Interest Coverage Ratio (Quarter)Interest Cover (Qtr) | -17.27 | -19.94 | -21.36 | -19.71 | -0.51 | -24.24 | -187.15 | -36.56 | -173.41 | -2.28 | -0.21 | -7.78 | -0.21 | -8.90 |
| Times Interest Earned (Quarter)Times Interest Earned (Qtr) | -17.27 | -19.94 | -21.36 | -19.71 | -0.51 | -24.24 | -187.15 | -36.56 | -173.41 | -2.28 | -0.21 | -7.78 | -0.21 | -8.90 |
| Valuation | ||||||||||||||
| Enterprise Value (Quarter)Enterprise Value (Qtr) | -21.06M | -41.32M | -20.96M | -120.75M | -104.88M | -179.29M | -167.13M | -152.11M | -138.25M | -127.15M | -220.19M | -107.58M | -92.85M | -125.01M |
| Return Ratios | ||||||||||||||
| Return on Capital Employed (Quarter)ROCE (Qtr) | -52.81% | -45.25% | -40.08% | -40.12% | -38.30% | -40.53% | -41.81% | -42.27% | -43.52% | -68.29% | ||||
| Return on Assets (Quarter)ROA (Qtr) | -0.01% | -0.01% | -0.01% | -0.01% | 0.00% | 0.00% | -0.01% | -0.01% | -0.01% | -0.02% |